Conference talks given

Oral Presentations


ESMO/IMPAKT PLENARY KEYNOTE LECTURE: Intratumour heterogeneity: A Challenge for Personalised Medicine

AACR Invited Speaker Intratumour heterogeneity: A Challenge for Personalised Medicine

AACR invited Speaker EU Framework 7 Consortium: Biomarker Discovery in Cancer Research

Invited Visiting Professor at Cedars Sinai Hospital

Invited speaker British Thoracic Oncology Group Intratumour Heterogeneity and Drug Resistance

Invited speaker Sage Bionetworks-Ruijin Joint Symposium in Cancer Research on Translational Medicine: Use of Biomarkers and Models of Disease
2nd EACR-OECI Joint Training Course ‘Molecular PATHOLOGY approach to cancer’ Invited course speaker

Invited speaker Institute of Cancer Research/Royal Marsden Hospital Personalised Medicine Conference.

NCRI Liverpool “Intratumour heterogeneity and drug resistance”

Invited Speaker Institute Gustav Roussy “Intratumour Heterogeneity and Personalised Medicine”

IV SOLTI Breast Cancer Research Group Scientific Meeting invited speaker

NKI/Netherlands Cancer Institute invited international speaker

Geoffrey Beene Symposium Memorial Sloan-Kettering Cancer Center “Cancer Heterogeneity”

NGS mini-symposium invited speaker “The Era of Next Generation Sequencing in Cancer”

“Prestige Seminars” in Oncology: “Meet the Oncology Expert”. Jules Bordet Institute, Brussels, Belgium

11th International Kidney Cancer Association Chicago October 2012 “The Challenge of Genetic Heterogeneity to RCC Translational Research”

Renal Cancer 2013 invited speaker “Advancing targeted therapies in cancer”

Insight on Genitourinary cancers Bari November 2012 “ Molecular Heterogeneity of RCC : Dilemma for treatment”

11th International Consensus Meeting “Individualised Therapy of Primary Breast Cancer in the Light of Intrinsic Subtypes and Tumour Heterogeneity: Invited speaker Tumour Heterogeneity

University of Gent Dept Medical Oncology 20th Anniversary lecture “Intratumour Heterogeneity”

The Promise Of Personalised Medicines Conference. Royal Society 2012 Invited speaker

BSMO-BORDET meeting Sixth Belgian Symposium on the
Integration of Molecular Biology Advances into Oncology Clinical Practice: Cancer genome of solid tumors : How to deal clinically with these findings November 2012


Invited Plenary NCRI: Intratumour heterogeneity and Personalised Medicine

CR-UK LRI and the Memorial Sloan-Kettering Cancer Institute Invited speaker

Invited speaker: International Symposium on Lung Cancer Leuven Belgium
“Intratumour heterogeneity between primary and metastatic sites”
Invited Speaker Mildred Scheel Cancer Conference, Bonn Germany

2013 ESMO European Cancer Congress, Keynote Lecture “Tumour Heterogeneity” and impact on personalised medicine and clinical practice.

2013 AACR: Invited Speaker at Major Symposium, “The Ruth Sager Memorial Symposium: Cancer Heterogeneity”

Inserm National Biobank Infrastructure Conference, France: Invited lecture on Tumour Heterogeneity

Lorne Genomics Conference Australia: Invited lecture Intratumour Heterogeneity

Keynote Lecture Eurocancer Meeting June 25-26, 2013 (Palais des Congrčs, Paris) on “INTRA-TUMOR HETEROGENEITY”.

Keynote Lecture EORTC Annual Meeting (EGAM) “A new angle to system biology / intra-tumor heterogeneity”. March 7th 2013

Plenary Session Lancet Oncology ASIA meeting Bangkok “INTRA-TUMOR HETEROGENEITY”. March 22 2013

Haematology and Oncology Targeted Therapies conference Sydney Plenary Speaker Sydney March 2013.

Keynote Lecture Tuscon Cancer Symposium, Ventana Medical Systems, March 2013

Nature CNIO Cancer Symposium Madrid October 2013 “Frontiers in Tumour Heterogeneity and Plasticity” Invited lecture

Invited Lecture: “tumor heterogeneity and tumor cell evolution” The 18th TJCC (Taiwan Joint Cancer Conference) in 13th-14th July in Taipei, Taiwan.

International Kidney Cancer Coalition – Conference 2013 invited lecture (Patient Advocacy groups).

American Society for Clinical Oncology (ASCO) 2013 Educational Session Tumour Heterogeneity

American Society for Clinical Oncology (ASCO) 2013 Invited Lecture Special Session Cancer Heterogeneity Monday, June 3, 2013

Presidential Symposium “Solid Tumour Heterogeneity”
German, Austrian and Swiss Societies for Hematology and Oncology October 2013

X Madrid Breast Cancer Conference Opening Lecture Tumor heterogeneity. A handicap for research in cancer

15th IASLC World Conference on Lung Cancer, WCLC 2013 Conference, October 27 – 30, 2013 Sydney. Invited Plenary Speaker

Drug Discovery 2013 Manchester September 4th Plenary Session

European Multidisciplinary Conference in Thoracic Oncology Keynote Lecture, Lugano Switzerland May 2013

ESMO/EORTC/NCI Markers in Cancer Meeting November 2013 Invited presentation on “Intratumoral heterogeneity: issues at diagnosis and with selective drug pressures”

6th Annual Cancer Center Symposium sponsored by the Cancer Center at Beth Israel Deaconess Medical Center Hitting the Target: Drug Resistance, Tumor Heterogeneity, and Targeted Therapy. Invited Speaker

Invited talk Third AACR International Conference on Frontiers in Basic Cancer Research

4th Annual Meeting of the Society for Translational Oncology VU Medical Centre Cancer Centre Amsterdam

Invited Speaker “Clonal Heterogeneity” Presidential Session, German, Austrian and Swiss Societies for Hematology and Oncology.Vienna


Invited Speaker EACR Conference: 23rd Biennial Congress of the European Association for Cancer Research

IRCAN Institute for Cancer and Ageing, Nice, Launch meeting Plenary Lecture


“Invited talk Third Symposium on Translational Genomics”, Natcher Conference Center, March 20-21, 2014 on the NIH campus in Bethesda, MD.”

ASCO Genitourinary Cancers Symposium, Invited Speaker General Session

AACR 2014 Educational Session Committee Member

Invited Speaker “Clonal Heterogeneity” Oncology at the Limits Meeting 2014

Invited Chair of Educational Symposium at AACR 2014

Invited Calloway Lectureship, Memorial Sloan-Kettering Cancer Center

Invited speaker British Thoracic Oncology Group NSCLC Intratumour Heterogeneity
Invited speaker Gordon Research Conference on Mutagenesis. Melia Golf Vichy Catalan, Girona, Spain, June 2014

Tumour seminar “Difficult questions in renal cancer research” World Health Organisation/IARC/NCI invited speaker

Invited Speaker ICC conference Madrid Making Sense of Technology & Cancer Heterogeneity

Breast Cancer Frontier Meeting Tokyo November 2014 Invited Speaker

Third Symposium on Translational Genomics National Cancer Institute Bethesda March 20th 2014 Invited Speaker

Stanford Cancer Institute “Tumour Heterogeneity: Implications for Targeted Therapies” Invited Keynote Speaker October 2014

TAT March 2014 Invited Speaker

Invited Speaker 15th International Meeting on Human Genome Variation and Complex Genome Analysis, Belfast, Northern Ireland, from 17-19 September, 2014

Invited Speaker Molecular Mechanisms in Cancer, Royal Tropical Institute in Amsterdam, The Netherlands November 13-14, 2014.

Wellcome Trust Cancer Pharmacogenomics and Targeted Therapies conference – 17 – 19th of September 2014 Session Chair and Invited Speaker

Invitation to give a lecture at the Cold Spring Harbor Asia Meeting on Precision Biology and Medicine to be held in Suzhou, China, May 4-8 2015

Invitation EACR Conference Series Precision Medicine for Cancer 2015, Neumünster Abbey, Luxembourg – Invited Speaker

11th Ipsen Cancer series meeting on Tumor Heterogeneity & Tumor Microenvironment in Mysore , India from Feb 26-March, 20I5 – invited speaker

EORTC-NCI-AACR symposium on molecular targets and cancer therapeutics, 18-21st Nov 2014

Plenary Lecture Novartis Lead Global XII Conference June 2014 “Tumour Heterogeneity and Cancer Evolution

Royal College of Physicians Goulstonian Lecture and Graham Bull Prize in Clinical Sciences February 2014

NCI Invited Speaker Intratumour Heterogeneity Bethesda USA March 2014

Intratumour Heterogeneity: Is it Relevant in RCC? Invited Speaker Kidney Cancer Society Meeting Dublin April 2014

Invited Speaker at the Cancer Pharmacogenomics and Targeted Therapies conference – 17 – 19th of September 2014

Invited Speaker at MRC Genome Instability Centre Sussex, October 2014

ESMO Invited Speaker October 2014 and Invited Discussant

Hong Kong Academy of Medicine, Hong Kong International Cancer Congress (HKICC) Invited Plenary Speaker November 2014

12th Breast Cancer frontier meeting Keynote Lecture November 2014 meeting Cellular Signalling and Cancer Therapeutics Amsterdam Invited Lecture November 2014

NCRI Liverpool November 2014 Vice Chairman


Immunology and Cancer (IRIC) 9th International Symposium titled “Molecular Targets in Cancer Genomics” Invited Speaker

Cold Spring Harbor The Biology of Cancer: Microenvironment, Metastasis and Therapeutics Meeting May 2015 Invited Speaker

Pezcoller Symposium, Trento, Italy. June 2015 invited speaker.

Plenary European Neuroendocrine Tumour Society Annual Conference 12th March 2015

5th EACR-OECI Joint Training Course “Molecular Pathology approach to cancer” Amsterdam 11th – 13th May 2015 invited Faculty

Second CRCL Symposium that will take place in Lyon, France, at the International Congress Centre, the 21st, 22nd and 23rd of September 2015

Invited Lecture “Comparative Genomics” ENS Lyon France, January 2015

Invited Visiting Professor February 2015, 100th anniversary of the Daniel den Hoed Cancer Centre, Erasmus MC Cancer Institute, Erasmus University Medical Centre Rotterdam

Leave a Comment

No Comments Yet!